Translational regulation of the mRNA encoding the ubiquitin peptidase USP1 involved in the DNA damage response as a determinant of Cisplatin resistance
出版年份 2016 全文链接
标题
Translational regulation of the mRNA encoding the ubiquitin peptidase USP1 involved in the DNA damage response as a determinant of Cisplatin resistance
作者
关键词
-
出版物
CELL CYCLE
Volume 15, Issue 2, Pages 295-302
出版商
Informa UK Limited
发表日期
2016-01-30
DOI
10.1080/15384101.2015.1120918
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- limma powers differential expression analyses for RNA-sequencing and microarray studies
- (2015) Matthew E. Ritchie et al. NUCLEIC ACIDS RESEARCH
- The Genetic and Biochemical Basis of FANCD2 Monoubiquitination
- (2014) Eeson Rajendra et al. MOLECULAR CELL
- A selective USP1–UAF1 inhibitor links deubiquitination to DNA damage responses
- (2014) Qin Liang et al. Nature Chemical Biology
- DNA damage: RNA-binding proteins protect from near and far
- (2014) Martin Dutertre et al. TRENDS IN BIOCHEMICAL SCIENCES
- Cisplatin Resistance Associated with PARP Hyperactivation
- (2013) J. Michels et al. CANCER RESEARCH
- Prognostic value of LIPC in non-small cell lung carcinoma
- (2013) Lorenzo Galluzzi et al. CELL CYCLE
- Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
- (2013) Muhammed Murtaza et al. NATURE
- miR-135a/b Modulate Cisplatin Resistance of Human Lung Cancer Cell Line by Targeting MCL1
- (2013) Li Zhou et al. PATHOLOGY & ONCOLOGY RESEARCH
- The Noncoding RNA Expression Profile and the Effect of lncRNA AK126698 on Cisplatin Resistance in Non-Small-Cell Lung Cancer Cell
- (2013) Yong Yang et al. PLoS One
- Genetic Variations in Epigenetic Genes Are Predictors of Recurrence in Stage I or II Non-Small Cell Lung Cancer Patients
- (2012) K. W. Wagner et al. CLINICAL CANCER RESEARCH
- Genome-Wide Association Study of Prognosis in Advanced Non-Small Cell Lung Cancer Patients Receiving Platinum-Based Chemotherapy
- (2012) L. Hu et al. CLINICAL CANCER RESEARCH
- USP1 regulates AKT phosphorylation by modulating the stability of PHLPP1 in lung cancer cells
- (2012) Zhang Zhiqiang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Non-specific chemical inhibition of the Fanconi anemia pathway sensitizes cancer cells to cisplatin
- (2012) Céline Jacquemont et al. Molecular Cancer
- Integrative Proteomics and Tissue Microarray Profiling Indicate the Association between Overexpressed Serum Proteins and Non-Small Cell Lung Cancer
- (2012) Yansheng Liu et al. PLoS One
- Genetic variations in the transforming growth factor-beta pathway as predictors of survival in advanced non-small cell lung cancer
- (2011) Moubin Lin et al. CARCINOGENESIS
- Selective and Cell-Active Inhibitors of the USP1/ UAF1 Deubiquitinase Complex Reverse Cisplatin Resistance in Non-small Cell Lung Cancer Cells
- (2011) Junjun Chen et al. CHEMISTRY & BIOLOGY
- Genetic Variations in Multiple Drug Action Pathways and Survival in Advanced Stage Non-Small Cell Lung Cancer Treated with Chemotherapy
- (2011) Y. Li et al. CLINICAL CANCER RESEARCH
- Alterations of microRNAs in Cisplatin-resistant Human Non-small Cell Lung Cancer Cells (A549/DDP)
- (2011) Qi Wang et al. EXPERIMENTAL LUNG RESEARCH
- Proteomic Analysis Identified DJ-1 as a Cisplatin Resistant Marker in Non-Small Cell Lung Cancer
- (2011) Hua-Zong Zeng et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Inactivation of Murine Usp1 Results in Genomic Instability and a Fanconi Anemia Phenotype
- (2009) Jung Min Kim et al. DEVELOPMENTAL CELL
- Translational reprogramming following UVB irradiation is mediated by DNA-PKcs and allows selective recruitment to the polysomes of mRNAs encoding DNA repair enzymes
- (2009) I. R. Powley et al. GENES & DEVELOPMENT
- Radiation-Induced Gene Translation Profiles Reveal Tumor Type and Cancer-Specific Components
- (2008) S. Kumaraswamy et al. CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More